Notice2023-11327
World Trade Center Health Program Scientific/Technical Advisory Committee
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 26, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with regulatory provisions, the Centers for Disease Control and Prevention (CDC) announces the following meeting for the World Trade Center Health Program Scientific/Technical Advisory Committee (WTCHP-STAC). This virtual meeting is open to the public. Time will be available for public comment.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 102 (Friday, May 26, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 102 (Friday, May 26, 2023)]
[Notices]
[Pages 34159-34161]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-11327]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2023-0040; NIOSH 248-K]
World Trade Center Health Program Scientific/Technical Advisory
Committee
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with regulatory provisions, the Centers for
Disease Control and Prevention (CDC) announces the following meeting
for the World Trade Center Health Program Scientific/Technical Advisory
Committee (WTCHP-STAC). This virtual meeting is open to the public.
Time will be available for public comment.
DATES: The meeting will be held on June 21, 2023, from 11 a.m. to 4
p.m., EDT, and June 22, 2023, from 11 a.m. to 1:30 p.m., EDT.
Written public comments must be received by June 22, 2023. Members
of the public who wish to address the WTCHP-STAC during the oral public
comment session must sign up to speak by June 14, 2023, at the email
address provided in the Procedure for Oral Public Comment section
below.
ADDRESSES: This is a virtual meeting conducted via Zoom. The public is
welcome to follow the proceedings via live webcast at the following
link: <a href="https://www.ustream.tv/channel/QyXBRzYjVCS">https://www.ustream.tv/channel/QyXBRzYjVCS</a>. No registration is
required. For additional information, please visit the World Trade
Center Health Program website at <a href="https://www.cdc.gov/wtc/stac_meeting.html">https://www.cdc.gov/wtc/stac_meeting.html</a>.
You may submit comments, identified by Docket No. CDC-2023-0040;
NIOSH 248-K by either of the methods listed below. CDC does not accept
comments by email.
<bullet> Federal eRulemaking Portal: <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
Follow the instructions for submitting comments.
<bullet> Mail: Ms. Sherri Diana, NIOSH Docket Office, National
Institute for Occupational Safety and Health, Centers for Disease
Control and Prevention, 1090 Tusculum Avenue, Mailstop C-34,
Cincinnati, Ohio 45226. Attn: Docket No. CDC-2023-0040; NIOSH 248-K.
Instructions: All submissions received must include the Agency name
and docket number (CDC-2023-0040; NIOSH 248-K). The docket will close
on June 22, 2023. All relevant comments, including any personal
information provided, will be posted without change to <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
FOR FURTHER INFORMATION CONTACT: Tania Carre[oacute]n-Valencia, Ph.D.,
M.S., Designated Federal Officer, World Trade Center Health Program
Scientific/Technical Advisory Committee, National Institute for
Occupational Safety and Health, Centers for Disease Control and
Prevention, 1600 Clifton Road NE, Mailstop R-12, Atlanta, Georgia
30329-4027. Telephone: (513) 841-4515; Email: <a href="/cdn-cgi/l/email-protection#b9cecdda94cacdd8daf9daddda97ded6cf"><span class="__cf_email__" data-cfemail="d9aeadbaf4aaadb8ba99babdbaf7beb6af">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Background: The World Trade Center (WTC) Health Program, including
the World Trade Center Health Program Scientific/Technical Advisory
Committee (WTCHP-STAC), was established by Title I of the James Zadroga
9/11 Health and Compensation Act of 2010, Public Law 111-347, as
[[Page 34160]]
amended by Public Law 114-113, Public Law 116-59, and Public Law 117-
328 (December 23, 2022), adding title XXXIII to the Public Health
Service (PHS) Act (codified at 42 U.S.C. 300mm to 300mm-62). Title
XXXIII of the PHS Act established the WTC Health Program within the
Department of Health and Human Services. The WTC Health Program
provides medical monitoring and treatment benefits to eligible
firefighters and related personnel, law enforcement officers, and
rescue, recovery, and cleanup workers who responded to the September
11, 2001, terrorist attacks in New York City, at the Pentagon, and in
Shanksville, Pennsylvania (responders), and to eligible persons who
were present in the dust or dust cloud on September 11, 2001, or who
worked, resided, or attended school, childcare, or adult daycare in the
New York City disaster area (survivors).
All references to the Administrator in this document mean the
Director of the National Institute for Occupational Safety and Health
(NIOSH), within the Centers for Disease Control and Prevention (CDC),
or his or her designee.
Purpose: The purpose of the WTCHP-STAC is to review scientific and
medical evidence and to make recommendations to the Administrator of
the WTC Health Program regarding additional WTC Health Program
eligibility criteria, potential additions to the List of WTC-Related
Health Conditions (List), and research regarding certain health
conditions related to the September 11, 2001, terrorist attacks. In
accordance with section 3312(a)(6)(G)(i)(II), the Administrator must
ask the WTCHP-STAC to review and evaluate any substantive amendment to
any existing WTC Health Program policy or procedure used to determine
whether sufficient evidence exists to support adding a health condition
to the List of WTC-Related Health Conditions.
The Administrator is responsible for the administration of the
WTCHP-STAC. CDC and NIOSH provide funding, staffing, and administrative
support services for the WTCHP-STAC. The WTCHP-STAC's charter was
reissued on May 12, 2023, and will expire on May 12, 2025.
Matters To Be Considered: In December 2022, the Consolidated
Appropriations Act, 2023 amended section 3341 of the PHS Act to direct
the Administrator, in consultation with the Secretary of Education, to
establish a new research cohort to conduct future research studies on
the health and educational impacts of ``exposure to airborne toxins, or
any other hazard or adverse condition, resulting from the September 11,
2001, terrorist attacks, including on the population of individuals who
were 21 years of age or younger at the time of exposure, including such
individuals who are screening-eligible WTC survivors or certified-
eligible WTC survivors.'' The main focus of the WTC Health Program STAC
meeting will be a discussion of the new youth research cohort being
established by the WTC Health Program. The meeting agenda will include
a presentation on establishing the cohort and the Program's
perspectives, as well as an overview of young survivors. In addition,
the WTC Survivors Steering Committee will lead presentations on young
survivors' views and community-based participatory research.
The meeting will also include a presentation and discussion about
substantive amendments to the existing Policy and Procedures for Adding
Non-Cancer Health Conditions to the List of WTC-Related Health
Conditions. Proposed revisions to the Policy and Procedures were
initially presented to the STAC at its meeting on February 9, 2023; the
presentation will detail further revisions made to the Policy and
Procedures in response to recommendations of the STAC at its previous
meeting.
Background documents as well as the agenda for this meeting are
available on the WTC Health Program website at <a href="https://www.cdc.gov/wtc/stac_meeting.html">https://www.cdc.gov/wtc/stac_meeting.html</a>. Agenda items are subject to change as priorities
dictate.
Public Participation
Interested parties may participate by submitting written views,
opinions, recommendations, and data. You may submit comments on any
topic related to the matters to be discussed by the Committee. Comments
received, including attachments and other supporting materials, are
part of the public record and subject to public disclosure. Do not
include any information in your comment or supporting materials that
you consider confidential or inappropriate for public disclosure. If
you include your name, contact information, or other information that
identifies you in the body of your comments, that information will be
on public display. CDC will review all submissions and may choose to
redact, or withhold, submissions containing private or proprietary
information such as Social Security numbers, medical information,
inappropriate language, or duplicate/near-duplicate examples of a mass-
mail campaign. CDC will carefully consider all comments submitted into
the docket.
Oral Public Comment: The public is welcome to participate, via
Zoom, during the public comment periods on June 21, 2023, from 1:20
p.m. to 1:50 p.m., EDT, and on June 22, 2023, from 11:05 a.m. to 11:35
a.m., EDT. Each commenter will be provided up to five minutes for
comment. A limited number of time slots are available and will be
assigned on a first-come, first-served basis.
Procedure for Oral Public Comment: Members of the public who wish
to address the WTCHP-STAC during the oral public comment sessions at
the June 21-22, 2023, WTCHP-STAC meeting must sign up to speak by
providing their name to Ms. Mia Wallace, Committee Management
Specialist, via email at <a href="/cdn-cgi/l/email-protection#652832040909040600250601064b020a13"><span class="__cf_email__" data-cfemail="aae7fdcbc6c6cbc9cfeac9cec984cdc5dc">[email protected]</span></a>, by June 14, 2023. Zoom
instructions and participation details will follow.
Written Public Comment: Written comments will also be accepted per
the instructions provided in the Addresses section above. Written
public comments received prior to the meeting will be part of the
official record of the meeting. The docket will close on June 22, 2023.
Policy on Redaction of Committee Meeting Transcripts (Public
Comment): Transcripts will be prepared and posted to <a href="https://www.regulations.gov">https://www.regulations.gov</a> within 60 days after the meeting. If individuals
making a comment give their name, no attempt will be made to redact the
name. NIOSH will take reasonable steps to ensure that individuals
making public comments are aware that their comments (including their
names, if provided) will appear in a transcript of the meeting posted
on a public website. Such reasonable steps include a statement read at
the start of the meeting stating that transcripts will be posted, and
names of speakers will not be redacted. If individuals in making a
statement reveal personal information (e.g., medical information) about
themselves, that information will not usually be redacted. The CDC
Freedom of Information Act coordinator will, however, review such
revelations in accordance with the Freedom of Information Act and, if
deemed appropriate, will redact such information. Disclosures of
information concerning third-party medical information will be
redacted.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other
[[Page 34161]]
committee management activities, for both the Centers for Disease
Control and Prevention and the Agency for Toxic Substances and Disease
Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-11327 Filed 5-25-23; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on May 26, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.